Funae Y - Search Results

1

CYP2A13 expressed in human bladder metabolically activates 4-aminobiphenyl.

Nakajima M, Itoh M, Sakai H, Fukami T, Katoh M, Yamazaki H, Kadlubar FF, Imaoka S, Funae Y, Yokoi T. Nakajima M, et al. Among authors: funae y. Int J Cancer. 2006 Dec 1;119(11):2520-6. doi: 10.1002/ijc.22136. Int J Cancer. 2006. PMID: 16988941 Free article.

2

Characterization of CYP2A6 involved in 3'-hydroxylation of cotinine in human liver microsomes.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Among authors: funae y. J Pharmacol Exp Ther. 1996 May;277(2):1010-5. J Pharmacol Exp Ther. 1996. PMID: 8627511

3

Role of human cytochrome P4502A6 in C-oxidation of nicotine.

Nakajima M, Yamamoto T, Nunoya K, Yokoi T, Nagashima K, Inoue K, Funae Y, Shimada N, Kamataki T, Kuroiwa Y. Nakajima M, et al. Among authors: funae y. Drug Metab Dispos. 1996 Nov;24(11):1212-7. Drug Metab Dispos. 1996. PMID: 8937855

4

Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.

Imaoka S, Tanaka S, Funae Y. Imaoka S, et al. Among authors: funae y. Biochem Int. 1989 Apr;18(4):731-40. Biochem Int. 1989. PMID: 2504167

5

Catalytic specificity of CYP2D isoforms in rat and human.

Hiroi T, Chow T, Imaoka S, Funae Y. Hiroi T, et al. Among authors: funae y. Drug Metab Dispos. 2002 Sep;30(9):970-6. doi: 10.1124/dmd.30.9.970. Drug Metab Dispos. 2002. PMID: 12167561

6

Mechanisms of chemopreventive effects of 8-methoxypsoralen against 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung adenomas.

Miyazaki M, Yamazaki H, Takeuchi H, Saoo K, Yokohira M, Masumura K, Nohmi T, Funae Y, Imaida K, Kamataki T. Miyazaki M, et al. Among authors: funae y. Carcinogenesis. 2005 Nov;26(11):1947-55. doi: 10.1093/carcin/bgi156. Epub 2005 Jun 15. Carcinogenesis. 2005. PMID: 15958517

7

CYP2C9*3 influences the metabolism and the drug-interaction of candesartan in vitro.

Hanatani T, Fukuda T, Ikeda M, Imaoka S, Hiroi T, Funae Y, Azuma J. Hanatani T, et al. Among authors: funae y. Pharmacogenomics J. 2001;1(4):288-92. doi: 10.1038/sj.tpj.6500063. Pharmacogenomics J. 2001. PMID: 11908770

8

Mutagenic activation of urinary bladder carcinogens by CYP4B1 and the presence of CYP4B1 in bladder mucosa.

Imaoka S, Yoneda Y, Matsuda T, Degawa M, Fukushima S, Funae Y. Imaoka S, et al. Among authors: funae y. Biochem Pharmacol. 1997 Sep 15;54(6):677-83. doi: 10.1016/s0006-2952(97)00216-5. Biochem Pharmacol. 1997. PMID: 9310344

9

A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).

Nunoya K, Yokoi T, Kimura K, Inoue K, Kodama T, Funayama M, Nagashima K, Funae Y, Green C, Kinoshita M, Kamataki T. Nunoya K, et al. Among authors: funae y. Pharmacogenetics. 1998 Jun;8(3):239-49. doi: 10.1097/00008571-199806000-00006. Pharmacogenetics. 1998. PMID: 9682269

10

Mutagenic activation of 3-methoxy-4-aminoazobenzene by mouse renal cytochrome P450 CYP4B1: cloning and characterization of mouse CYP4B1.

Imaoka S, Hiroi T, Tamura Y, Yamazaki H, Shimada T, Komori M, Degawa M, Funae Y. Imaoka S, et al. Among authors: funae y. Arch Biochem Biophys. 1995 Aug 1;321(1):255-62. doi: 10.1006/abbi.1995.1393. Arch Biochem Biophys. 1995. PMID: 7639529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

243 results

Search Page